Neo-science Group Competitors and Similar CompaniesClear all
Neo-science Group's competitors and similar companies include Epigenomics, Avacta Group, Indi Molecular and Biomatrica.
 Neo-science Group Neo-Science and Group is a company that offers high-quality solutions and services to the clinical and scientific. |  Epigenomics Epigenomics AG isa molecular diagnostics company developing and manufacturinga pipeline of products for the diagnosis of cancer. |  Avacta Group Avacta Group plc is a provider of technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics |  Indi Molecular Indi Molecular is an emerging life sciences company that is developing a synthetic class of diagnostic and therapeutic agents with antibody-like properties: protein-catalyzed capture agents. |  Biomatrica Biomatrica: The Biostability Company. We are the leaders at stabilizing biological samples and assays at ambient temperature. | |
Founding Date | Founding Date N/A | Founding Date 1998 | Founding Date 2003 | Founding Date 2013 | Founding Date 2004 |
Type | Type Private | Type Public | Type Public | Type Private | Type Subsidiary |
Tags | |||||
Locations | Locations Dubai, AE HQ | Locations Berlin, DE HQ San Diego, US | Locations Wetherby, GB HQ London, GB Whittlesford, GB | Locations Culver City, US HQ | Locations San Diego, US HQ |
Employees | Employees 166% decrease | Employees 329% decrease | Employees 154 | Employees 30 | Employees 109% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 604.8 k | Valuation ($) 264.5 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €24k (FY, 2025) | Revenue (est.) £6.3m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods £3.3m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit €31k (FY, 2025) | Gross profit £3m (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income N/A | Net income (€314k) (FY, 2025) | Net income (£38.4m) (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 11.7m | Total funding raised N/A | Total funding raised $ 11.5m | Total funding raised $ 9.2m |
For sources of this data, please see the company profile
View Company Profiles
Epigenomics
HQ
Berlin, DE
Employees
32↓ 9% decrease
Epigenomics AG isa molecular diagnostics company developing and manufacturinga pipeline of products for the diagnosis of cancer.
View companyAvacta Group
HQ
Wetherby, GB
Employees
154
Avacta Group plc is a provider of technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics
View companyIndi Molecular
HQ
Culver City, US
Employees
30
Indi Molecular is an emerging life sciences company that is developing a synthetic class of diagnostic and therapeutic agents with antibody-like properties: protein-catalyzed capture agents.
View companyBiomatrica
HQ
San Diego, US
Biomatrica: The Biostability Company. We are the leaders at stabilizing biological samples and assays at ambient temperature.
View company